Brind.

IceCure Medical and Straumann are both healthcare companies facing market scrutiny.

1 report, 1 independent Updated Aug 4

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

IceCure Medical Straumann

Keep exploring

The entities involved

IceCure Medical
Nothing else this week.
Straumann
company
- MarketBeat reports on average recommendation of Moderate Buy for Straumann, while Citigroup restated a sell rating and Morgan Stanley reaffirmed an underweight rating.Sat 10:22

Coverage

Newest first; wire copies grouped

Aug 4themarketsdaily.com